Trial Profile
Ocular Sarcoidosis Open Label Trial of ACTHAR Gel
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2023
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Anterior uveitis; Intermediate uveitis; Panuveitis; Posterior uveitis; Sarcoidosis
- Focus Therapeutic Use
- 30 Jun 2022 Status changed from active, no longer recruiting to completed.
- 08 Mar 2022 Planned End Date changed from 1 Dec 2022 to 1 Apr 2022.
- 08 Mar 2022 Status changed from recruiting to active, no longer recruiting.